These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4484660)

  • 1. Influence of first-pass effect on the systemic availability of propoxyphene.
    Perrier D; Gibaldi M
    J Clin Pharmacol New Drugs; 1972; 12(11):449-52. PubMed ID: 4484660
    [No Abstract]   [Full Text] [Related]  

  • 2. d-Propoxyphene kinetics after single oral and intravenous doses in man.
    Gram LF; Schou J; Way WL; Heltberg J; Bodin NO
    Clin Pharmacol Ther; 1979 Oct; 26(4):473-82. PubMed ID: 487695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of l-propoxyphene on plasma levels and analgesic activity of d-propoxyphene in the rat.
    Murphy PJ; Nickander RC; Bellamy GM; Kurtz WL
    J Pharmacol Exp Ther; 1976 Nov; 199(2):415-22. PubMed ID: 978493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of propoxyphene in man. II. Pharmacokinetics.
    Wagner JG; Welling PG; Sedman AJ
    Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):381-8. PubMed ID: 5046052
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of ethanol intake on propoxyphene absorption and biotransformation in dogs.
    Olsen H; Aune H; Lilleaasen P; Gulliksen M; Bodd E; Mørland J
    Alcohol Clin Exp Res; 1986 Aug; 10(4):393-6. PubMed ID: 3530016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concentration of propoxyphene in human plasma following oral, intramuscular, and intravenous administration.
    Wolen RL; Gruber CM; Kiplinger GF; Scholz NE
    Toxicol Appl Pharmacol; 1971 Jul; 19(3):480-92. PubMed ID: 4936997
    [No Abstract]   [Full Text] [Related]  

  • 7. Disposition of propoxyphene and norpropoxyphene in man after a single oral dose.
    Verebely K; Inturrisi CE
    Clin Pharmacol Ther; 1974 Mar; 15(3):302-9. PubMed ID: 4815955
    [No Abstract]   [Full Text] [Related]  

  • 8. Propoxyphene and norpropoxyphene plasma concentrations in the anephric patient.
    Gibson TP; Giacomini KM; Briggs WA; Whitman W; Levy G
    Clin Pharmacol Ther; 1980 May; 27(5):665-70. PubMed ID: 7371364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analgesia, plasma levels, and dosage of propoxyphene.
    Waife SO; Gruber CM; Rodda BE; Nash JF
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):177-81. PubMed ID: 950259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of propoxyphene in man. I. Following oral administration of the drug in solution and capsule forms.
    Wagner JG; Welling PG; Roth SB; Sakmar E; Lee KP; Walker JE
    Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):371-80. PubMed ID: 4558245
    [No Abstract]   [Full Text] [Related]  

  • 11. Problems and solutions to single-dose testing of analgesics: comparison of propoxyphene, codeine, and fenoprofen.
    Waife SO; Gruber CM; Rodda BE; Nash JF
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):301-4. PubMed ID: 1165140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous estimation of propoxyphene-do and propoxyphene-d2 levels by quantitative mass fragmentography. Potential utility in multidose investigations.
    Sullivan HR; Wood PG; McMahon RE
    Biomed Mass Spectrom; 1976 Oct; 3(5):212-6. PubMed ID: 974235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-propoxyphene and norpropoxyphene kinetics after the oral administration of D-propoxyphene: a new approach to liver function?
    Horsmans Y; Desager JP; Daenens C; Harvengt C; Geubel AP
    J Hepatol; 1994 Sep; 21(3):283-91. PubMed ID: 7836695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration of propoxyphene in human plasma following repeated oral doses.
    Wolen RL; Gruber CM; Kiplinger GF; Scholz NE
    Toxicol Appl Pharmacol; 1971 Jul; 19(3):493-7. PubMed ID: 5571352
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute effect of ethanol on hepatic first-pass elimination of propoxyphene in rats.
    Oguma T; Levy G
    J Pharmacol Exp Ther; 1981 Oct; 219(1):7-13. PubMed ID: 7288618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of plasma concentrations of propoxyphene utilizing a hybrid principal component-analysis of variance technique. Case II--equipotent doses.
    Rodda BE; Scholz NE; Gruber CM; Wolen RL
    Toxicol Appl Pharmacol; 1971 Jul; 19(3):563-71. PubMed ID: 4937003
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Disposition of propoxyphene in children.
    Wilson JT
    Acta Pharm Suec; 1974 Dec; 11(6):651-2. PubMed ID: 1136803
    [No Abstract]   [Full Text] [Related]  

  • 18. Propoxyphene and norpropoxyphene kinetics after single and repeated doses of propoxyphene.
    Inturrisi CE; Colburn WA; Verebey K; Dayton HE; Woody GE; O'Brien CP
    Clin Pharmacol Ther; 1982 Feb; 31(2):157-67. PubMed ID: 7056023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of levopropoxyphene N-oxide to propoxyphene by dogs in vivo and rat liver microsomal fraction in vitro.
    McMahon RE; Sullivan HR
    Xenobiotica; 1977 Jun; 7(6):377-82. PubMed ID: 610054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic studies of propoxyphene I:Effect of portacaval shunt on systemic availability in dogs.
    Giacomini KM; Nakeeb SM; Levy G
    J Pharm Sci; 1980 Jul; 69(7):786-9. PubMed ID: 7391940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.